← Cigna Group

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income (Loss) Attributable to Parent $1.8b $2.2b $2.6b $5.1b $8.5b $5.4b $6.7b $5.4b $3.8b $6.0b
Net Income (Loss) Available to Common Stockholders, Basic $1.8b $2.2b $2.6b $5.1b $8.5b $5.4b $6.7b $5.2b $3.4b $6.3b
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest — $2.2b $2.6b $5.1b $8.5b $5.4b $6.7b $5.4b $3.8b $6.3b
Net Income (Loss) Attributable to Noncontrolling Interest — ($5.0m) $9.0m $16.0m $31.0m $50.0m $78.0m $208.0m $344.0m $331.0m
Depreciation, Depletion and Amortization $610.0m $566.0m $695.0m $3.7b $2.8b $2.9b $2.9b $3.0b $2.8b $2.8b
Amortization of Intangible Assets — $115.0m $235.0m $2.9b $2.0b $2.0b $1.9b $1.8b $1.7b $1.7b
Deferred Policy Acquisition Costs, Amortization Expense — $322.0m $406.0m $483.0m $502.0m $478.0m $319.0m — — —
Deferred Income Tax Expense (Benefit) $74.0m $242.0m ($101.0m) ($313.0m) ($386.0m) ($220.0m) ($480.0m) ($1.7b) ($95.0m) $326.0m
Share-based Payment Arrangement, Expense — $178.0m $180.0m $299.0m $289.0m $268.0m $264.0m $286.0m $308.0m $291.0m
Gain (Loss) on Disposition of Business — — — — $4.2b $0 $1.7b ($1.5b) $24.0m $13.0m
Gain (Loss) on Extinguishment of Debt $0 ($321.0m) $0 ($2.0m) ($199.0m) ($141.0m) $0 $0 — —
Income Tax Expense (Benefit) $74.0m $1.4b $935.0m $1.4b $2.4b $1.4b $1.6b $141.0m $1.5b $1.5b
Other Nonoperating Income (Expense) — ($252.0m) ($498.0m) ($1.7b) ($1.4b) ($1.2b) ($1.2b) ($1.4b) ($1.4b) ($1.4b)
Debt extinguishment gain $0 $321.0m $0 $2.0m $199.0m $141.0m $0 $0 — —
Renewable energy tax credit equity investments — — — — — — ($125.0m) ($313.0m) ($1.0b) ($1.1b)
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Inventories — $72.0m $107.0m ($149.0m) $504.0m $557.0m $1.1b $868.0m $1.0b $646.0m
Debt Securities, Available-for-sale, Allowance for Credit Loss, Not Previously Recorded — — — — ($82.0m) — — — — —
Goodwill — $6.2b $44.5b $44.6b $44.6b $45.8b $45.8b $44.3b $44.4b $44.9b
Investment losses, net — — — — — — $487.0m $78.0m $2.7b $24.0m
Net (gain) loss on sale of businesses — — $0 $0 ($4.2b) $0 ($1.7b) $1.5b ($24.0m) ($13.0m)
Accounts receivable, net $663.0m ($233.0m) $705.0m ($713.0m) ($1.5b) ($2.8b) ($2.2b) ($1.7b) ($7.4b) ($4.6b)
Inventories $30.0m ($72.0m) ($107.0m) $149.0m ($504.0m) ($557.0m) ($1.1b) ($868.0m) ($1.0b) ($646.0m)
Reinsurance recoverable and Other assets $246.0m $115.0m ($234.0m) ($277.0m) $230.0m ($389.0m) ($38.0m) ($539.0m) ($485.0m) ($897.0m)
Insurance liabilities $683.0m $506.0m $560.0m $575.0m $841.0m $967.0m $291.0m $584.0m ($591.0m) $1.2b
Pharmacy and other service costs payable ($46.0m) $35.0m ($842.0m) ($192.0m) $2.9b $2.0b $1.8b $2.0b $8.8b $1.9b
Accounts payable and Accrued expenses and other liabilities $171.0m $696.0m $332.0m $1.3b $1.3b ($77.0m) $1.6b $3.5b $1.1b $2.8b
Other, net ($72.0m) ($22.0m) ($312.0m) ($107.0m) ($175.0m) $39.0m ($23.0m) ($413.0m) ($349.0m) ($624.0m)
Debt securities and equity securities — ($5.6b) ($5.6b) ($4.3b) ($4.8b) ($3.6b) ($2.8b) ($4.3b) ($1.4b) ($5.8b)
Commercial mortgage loans ($165.0m) ($430.0m) ($312.0m) ($307.0m) ($113.0m) ($327.0m) ($161.0m) ($118.0m) ($54.0m) ($117.0m)
Other (primarily short-term and other long-term investments) ($1.7b) ($1.1b) ($1.2b) ($1.8b) ($1.9b) ($2.6b) ($1.6b) ($1.2b) ($1.3b) ($1.4b)
Acquisitions, net of cash acquired ($4.0m) ($209.0m) ($24.5b) ($153.0m) ($139.0m) ($1.8b) $0 ($447.0m) ($131.0m) ($597.0m)
Deposits and interest credited to contractholder deposit funds $1.5b $1.2b $1.0b $955.0m $1.0b $153.0m $164.0m $167.0m $166.0m $152.0m
Withdrawals and benefit payments from contractholder deposit funds ($1.4b) ($1.4b) ($1.2b) ($1.1b) ($979.0m) ($168.0m) ($220.0m) ($223.0m) ($228.0m) ($253.0m)
Net change in short-term debt, excluding term loan — — $1.5b ($681.0m) $60.0m $975.0m ($2.1b) $1.2b ($402.0m) ($927.0m)
Net proceeds on issuance of term loan — — $0 $0 $1.4b $0 $0 $0 $0 $2.0b
Repayment of term loan — — $0 $0 ($1.4b) $0 $0 $0 $0 ($2.0b)
Net Cash Provided by (Used in) Operating Activities $4.0b $4.1b $3.8b $9.5b $10.3b $7.2b $8.7b $11.8b $10.4b $9.6b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($461.0m) $471.0m $528.0m $1.1b ($1.1b) ($1.2b) ($1.3b) ($1.6b) ($1.4b) ($1.2b)
Payments to Acquire Businesses, Net of Cash Acquired — $209.0m $24.5b $153.0m $139.0m $1.8b $0 $447.0m $131.0m $597.0m
Other sales, maturities and repayments (primarily short-term and other long-term investments) $1.4b $1.7b $734.0m $1.3b $1.6b $1.9b $1.0b $586.0m $752.0m $884.0m
Divestitures, net of cash sold — — $0 $0 $5.6b ($61.0m) $4.8b $13.0m $521.0m $3.0b
Payments for (Proceeds from) Other Investing Activities — $0 $12.0m $11.0m ($23.0m) ($97.0m) $170.0m $332.0m ($58.0m) $34.0m
Net Cash Provided by (Used in) Investing Activities ($2.6b) ($1.7b) ($26.4b) ($734.0m) $3.0b ($3.6b) $3.1b ($5.2b) ($2.1b) ($4.4b)
Cash flows from financing activities:
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale — $2.1b $2.2b — — — — — — —
Proceeds from Issuance of Long-term Debt $0 $1.6b $22.9b $0 $3.5b $4.3b $0 $1.5b $4.5b $4.5b
Net proceeds on issuance of long-term debt $0 $1.6b $22.9b $0 $3.5b $4.3b $0 $1.5b $4.5b $4.5b
Repayments of Long-term Debt — $1.2b $131.0m $4.5b $8.0b $4.6b $500.0m $3.0b $3.0b $4.2b
Payments for debt extinguishment $0 ($313.0m) $0 ($3.0m) ($212.0m) ($136.0m) $0 $0 — —
Repayment of long-term debt $0 ($1.2b) ($131.0m) ($4.5b) ($8.0b) ($4.6b) ($500.0m) ($3.0b) ($3.0b) ($4.2b)
Proceeds from Issuance of Common Stock $36.0m $131.0m $68.0m $224.0m $376.0m $326.0m $389.0m $187.0m $305.0m $203.0m
Issuance of common stock $36.0m $131.0m $68.0m $224.0m $376.0m $326.0m $389.0m $187.0m $305.0m $203.0m
Payments for Repurchase of Common Stock $139.0m $2.7b $342.0m $2.0b $4.0b $7.7b $7.6b $2.3b $7.0b $3.6b
Payments of Ordinary Dividends, Common Stock — — — — — $1k $1k $1k $2k $2k
Repurchase of common stock ($139.0m) ($2.7b) ($342.0m) ($2.0b) ($4.0b) ($7.7b) ($7.6b) ($2.3b) ($7.0b) ($3.6b)
Common stock dividend paid ($10.0m) ($10.0m) $0 ($15.0m) ($15.0m) ($1.3b) ($1.4b) ($1.4b) ($1.6b) ($1.6b)
Proceeds from (Payments for) Other Financing Activities — ($22.0m) ($312.0m) ($107.0m) ($175.0m) $39.0m ($23.0m) ($413.0m) ($349.0m) ($624.0m)
Net Cash Provided by (Used in) Financing Activities ($225.0m) ($2.7b) $23.5b ($7.2b) ($8.5b) ($8.2b) ($11.2b) ($4.3b) ($7.6b) ($6.4b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect — $55.0m ($24.0m) $1.6b $4.8b ($4.7b) $428.0m $2.4b $594.0m ($1.2b)
Net (decrease) increase in cash, cash equivalents and restricted cash — ($213.0m) $883.0m $1.6b $4.8b ($4.7b) $428.0m $2.4b $594.0m ($1.2b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents — $55.0m ($24.0m) $4.7b $10.2b $5.1b $6.0b $7.9b $7.6b $7.7b
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash — $55.0m ($24.0m) ($8.0m) $41.0m ($65.0m) ($86.0m) $16.0m ($20.0m) $32.0m
Cash, cash equivalents and restricted cash January 1, including held for sale assets — $3.0b $3.9b $5.4b $10.2b $5.5b $5.5b $8.3b $8.9b $7.7b
Cash and cash equivalents reclassified to assets of businesses held for sale — $0 $0 ($743.0m) $0 ($425.0m) $0 ($467.0m) ($1.3b) $0
Cash, cash equivalents and restricted cash and cash equivalents December 31, — $3.0b $3.9b $4.7b $10.2b $5.1b $6.0b $7.9b $7.6b $7.7b
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $244.0m $240.0m $267.0m $1.6b $1.4b $1.3b $1.2b $1.3b $1.3b $1.4b
Income Taxes Paid, Net — $1.0b $1.0b $1.8b $1.8b $2.2b $1.9b $1.5b $898.0m $399.0m

Data sourced from SEC EDGAR 10-K filings via EdgarTools. Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.